| Role of Cardiac Myosin Binding Protein-C in the Regulation of Myocardial Contraction |
Grant |
2,263,628.00 |
Research |
Samantha Harris |
Physiology |
04/2024 |
| Safety and Microbiological Activity of a Single Dose of Bacteriophage Therapy in Cystic Fibrosis Subjects Colonized with Pseduomonas aeruginosa (PHAGE) |
Cooperative Agreement |
186,000.00 |
Clinical Trial |
David Miller |
Asthma/Airway Disease Rsch Ctr |
04/2024 |
| STORM-PE: A Prospective, Multicenter, Randomized Controlled Trial Evaluating Anticoagulation Alone vs Anticoagulation plus Mechanical Aspiration with the Indigo Aspiration System for the Treatment of |
Contract |
107,573.00 |
Clinical Trial |
Gregory Woodhead |
Medical Imaging |
04/2024 |
| Targeting Cardiac Fibroblast Activation, a Cross-Border Collaboration |
Grant |
10,000.00 |
Research |
Taben Hale |
COM Phx Basic Medical Sci |
04/2024 |
| Targeting p53-mutated head and neck squamous cell carcinoma. |
Grant |
749,993.00 |
Research |
Carlos Caulin |
Otolaryngology |
04/2024 |
| The Mind and Appetite After Midnight |
Grant |
4,320.00 |
Research |
Kathryn Kennedy |
Psychiatry |
04/2024 |
| The Role of Hdac9 Activation in the Pathogenesis of E-Cigarette-Induced Atherosclerosis by Promoting Endothelial-Mesenchymal Transition |
Grant |
225,000.00 |
Research |
Chen-wei Liu |
COM Phx Basic Medical Sci |
04/2024 |
| The Role of Na+/H+ Exchange in Shaping Gut Microbial-Epithelial Interactions and Susceptibility to Enteric Infection During Postnatal Development |
Grant |
224,991.00 |
Research |
Claudio Bernardazzi de Miranda Azevedo |
Pediatrics |
04/2024 |
| The Role of S-Glutathione in Regulating Cardiac Myosin Binding Protein-C Function |
Grant |
210,372.00 |
Research Training |
Angela Greenman |
Cellular & Molecular Medicine |
04/2024 |
| University of Arizona Prevention Mobile Health Unit |
Cooperative Agreement |
102,783.00 |
Other Sponsored Activity |
Sheila Soto |
Public Hlth Prac & Trans Rsch |
04/2024 |
| VA IPA for Iyengar |
Contract |
49,999.00 |
Research |
Michael Fallon |
COM Phx Internal Medicine |
04/2024 |
| 1/2 - Pediatric Prehospital Airway Resuscitation Trial |
Cooperative Agreement |
116,052.00 |
Research |
Joshua Gaither |
Dept of Emergency Medicine |
03/2024 |
| 1/2 Trauma Resuscitation with Group O Whole Blood Or Products (TROOP) Trial |
Cooperative Agreement |
267,876.00 |
Research |
Bellal Joseph |
Surgery |
03/2024 |
| A Phase 1b Study of the OxPhos Inhibitor ME-344 Combined With Bevacizumab in Previously Treated Metastatic Colorectal Cancer |
Contract |
502,760.72 |
Clinical Trial |
Aaron Scott |
Cancer Center Division |
03/2024 |
| A Phase 2b, Multinational, Randomized, Double-blind Study to Investigate the Efficacy and Safety of Redasemtide (S-005151) Compared With Placebo in Adult Participants With Acute Ischemic Stroke Who Ar |
Contract |
470,257.20 |
Clinical Trial |
Firas Kaddouh |
Neurology |
03/2024 |
| A Randomized Phase 2 Non-inferiority Trial of (Z)-endoxifen and Exemestane + Goserelin as Neoadjuvant Treatment in Premenopausal Women with ER+/HER2- Breast Cancer |
Contract |
300,639.36 |
Clinical Trial |
Sima Ehsani Chimeh |
Cancer Center Division |
03/2024 |
| A Randomized, Double-Blind, Dose-Ranging, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Pln-74809 (Bexotegrast) for the Treatment of Idiopathic Pulmonary Fibrosis (BEACON-IPF) |
Contract |
221,588.92 |
Clinical Trial |
Sachin Chaudhary |
Medicine |
03/2024 |
| A Randomized, Double-blind, Placebo-controlled, Multicenter Study to Assess the Efficacy and Safety of Rifaximin Soluble Solid Dispersion (SSD) Tablets for the Delay of Encephalopathy Decompensation i |
Contract |
556,127.00 |
Clinical Trial |
Moises Nevah Rubin |
COM Phx Internal Medicine |
03/2024 |
| A Randomized, Phase 2, Double-blind, Placebo-controlled Study to Investigate the Safety and Efficacy of KER-012 in Combination with Background Therapy in Adult Participants with Pulmonary Arterial Hyp |
Contract |
555,665.52 |
Clinical Trial |
Franz Rischard |
Medicine |
03/2024 |
| An Open-label, Controlled, Randomized Phase 3 Trial Evaluating 12-month Kidney Function in Highly Sensitized (cPRA > 99.9%) Kidney Transplant Patients With Positive Crossmatch Against a Deceased Donor |
Contract |
246,785.52 |
Clinical Trial |
Kenneth Bodziak |
COM Phx Internal Medicine |
03/2024 |
